Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hemangioma × Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 34 Prostatic Neoplasms 16 Melanoma 14 Lung Neoplasms 13 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Uterine Cervical Neoplasms 6 Leukemia 6 Breast Neoplasms, Male 6 Urinary Bladder Neoplasms 5 Precancerous Conditions 5 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 5 Adenocarcinoma Of Esophagus 5 Pancreatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Congenital Abnormalities 4 Barrett Esophagus 4 Vulvar Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

Propranolol 6 Prednisolone 3 Timolol 2 Steroids 2 Saline Solution 2 Prednisone 2 Adrenergic beta-Antagonists 2 Urine Specimen Collection 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Nadolol 1 Methylprednisolone 1 Leuprolide 1 Lasers, Semiconductor 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Bleomycin 1 Biopsy 1 Atenolol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334930 2016-08-22

PEC-Hem

University Hospital, Bordeaux

Hemangioma, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡